Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 27, 2021

SELL
$472.8 - $558.54 $244,910 - $289,323
-518 Closed
0 $0
Q1 2021

Apr 20, 2021

SELL
$446.73 - $548.2 $2,233 - $2,741
-5 Reduced 0.96%
518 $245,000
Q4 2020

Jan 25, 2021

BUY
$478.3 - $607.98 $250,150 - $317,973
523 New
523 $253,000
Q3 2020

Oct 13, 2020

SELL
$544.75 - $658.21 $278,367 - $336,345
-511 Closed
0 $0
Q2 2020

Jul 29, 2020

SELL
$493.32 - $643.92 $9,866 - $12,878
-20 Reduced 3.77%
511 $318,000
Q1 2020

May 12, 2020

BUY
$336.18 - $494.43 $178,511 - $262,542
531 New
531 $259,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $80.9B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track V Wealth Advisors LLC Portfolio

Follow V Wealth Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of V Wealth Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on V Wealth Advisors LLC with notifications on news.